The National Cancer Institute recently published scientific articles on cancer and cannabis to help individuals better understand questions they may have on how patients perceive marijuana. The articles, which were published in a special issue of the “JNCI Monographs,” discuss the results from federal surveys on patients from cancer centers in different parts of the country. This includes areas where marijuana is still outlawed, allowed for medical use only or is legal.
In the introduction, the National Cancer Institute explained that the project’s objective was to address major gaps in knowledge in our understanding of marijuana and cancer. This would, in turn, allow readers to learn more about how patients with cancer accessed and used the substance, and evaluate the perceived benefits and risks with the drug’s use, among other things.
One of the studies included in the report focused on patients who used medical cannabis to manage cancer-related pain as an alternative to opioids. The researchers discovered that their findings showed that patients were using marijuana regardless of its legality in the state they resided in.
A separate analysis discovered that the most common consumption mode for marijuana by patients was gummies and smoking, with the main reasons for use being mood, insomnia and pain. Another study examined the use of cannabis by patients living with cancer in different stages, discovering that survivors who had been diagnosed with the illness at its advanced stages were more likely to consider using marijuana than patients who had been diagnosed at the early stages.
Another study that was included in the report examined prescription opioids and marijuana use among cancer patients, with researchers observing that marijuana was used to manage symptoms of cancer, as well as an alternative to opioids.
In their report, the researchers noted that most participants used marijuana because it was safer, while others preferred it because it was less addictive. Some also preferred it because it had fewer side effects.
Professor Rebecca Ashare, the lead author of this study, revealed that the focus needed to be on educating providers on how to discuss the co-use of opioids, marijuana as well as their substitution.
The recently published monograph can be found online.
In other news, research published earlier in the year found that some minor cannabinoids may have anti-cancer effects on leukemia. The study examined minor cannabinoids and multiple myeloma, testing how cell models responded to cannabinoids such as CBN, CBC, CBG and CBDV.
The researchers determined that these compounds held the potential to be anticancer agents for multiple myeloma, primarily because of their cytotoxic effect on the cancer’s cell lines.
The growing attention that federal health authorities are giving to medical marijuana is likely to send positive signals to cannabis companies such as Tilray Brands Inc. (NASDAQ: TLRY) (TSX: TLRY) regarding the possible future changes in marijuana policy at the federal level.
About CannabisNewsWire
CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer
CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CannabisNewsWire is powered by IBN
